ketotifen has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sánchez-Patán, F | 2 |
Aller, MA | 2 |
Cuellar, C | 2 |
Rodero, M | 2 |
Corcuera, MT | 1 |
Nava, MP | 1 |
Gómez, F | 1 |
Blanco, MD | 1 |
Guerrero, S | 1 |
Anchuelo, R | 2 |
Muñiz, E | 1 |
Alonso, MJ | 1 |
Teijón, JM | 1 |
Arias, J | 2 |
Vara, E | 1 |
Garcia, C | 1 |
Saavedra, Y | 1 |
Vergara, P | 1 |
2 other studies available for ketotifen and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats.
Topics: Animals; Anti-Allergic Agents; Enzyme-Linked Immunosorbent Assay; Hypertension, Portal; Inflammation | 2008 |
Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids.
Topics: Animals; Anti-Inflammatory Agents; Cell Movement; Chymases; Disease Models, Animal; Eicosanoids; Hyp | 2008 |